HOUSTON, Oct. 21, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a clinical-stage pharmaceutical company developing targeted radiotherapeutics with advanced platform ...
The MarketWatch News Department was not involved in the creation of this content. Expands commercial readiness and diagnostic, manufacturing footprint Appoints new leadership in commercial strategy ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results